QDEL — QuidelOrtho Corp
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1906324 ·
Last close
$10.94
Market Cap
$750.22M
52W High
$35.58
52W Low
$9.92
ADV30
1,387,460
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 619,800,000 | 263,800,000 | -27,400,000 | -91,800,000 | 5,628,700,000 | 140,400,000 | 3,777,300,000 |
| Dec 2025 | 723,600,000 | 320,400,000 | -37,300,000 | -130,700,000 | 5,769,300,000 | 169,800,000 | 3,848,800,000 |
| Sep 2025 | 699,900,000 | 335,600,000 | 45,200,000 | -733,000,000 | 5,675,100,000 | 98,100,000 | 3,638,700,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,600,000
Investing CF
$-170,500,000
Financing CF
$175,800,000
CapEx
$-166,000,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-17.82
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,087,800,000
Inventory
$611,500,000
Receivables
$486,700,000
ST Investments
$0
EBIT TTM
$-989,600,000
Pretax Income TTM
$-1,178,400,000
Interest Exp TTM
$188,800,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,674,200,064
EBITDA
$484,600,000
Free Cash Flow
$146,762,496
Enterprise Value
$3,759,918,592
Total Cash
$123,400,000
Total Debt
$3,075,500,032
Shares Out
68,575,427
Trailing EPS
$-15.43
Book Value
$25.99
ROE
-45.9%
ROA
0.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,730,200,000 | 54,800,000 | -1,131,800,000 | 5,769,300,000 | 3,848,800,000 | 1,920,500,000 | 105,200,000 |
| Dec 2024 | 2,782,900,000 | 45,800,000 | -2,052,000,000 | 6,423,600,000 | 3,439,100,000 | 2,984,500,000 | 83,000,000 |
| Dec 2023 | 2,997,800,000 | 257,000,000 | -10,100,000 | 8,563,100,000 | 3,557,200,000 | 5,005,900,000 | 280,200,000 |
| Dec 2022 | 3,266,000,000 | 982,500,000 | 548,700,000 | 8,855,800,000 | 3,921,200,000 | 4,934,600,000 | 885,300,000 |
TTM Snapshot
Revenues TTM
$2,947,700,000
NetIncome TTM
$-26,100,000
OpCashFlow TTM
$0
Assets (Latest)
$5,769,300,000
Forward EPS
$1.44
Max Pain — expiry 2026-12-18
max pain strike: $15.00 · spot: $10.94 · call oi: 859 · put oi: 3,814
Expected Move to 2026-12-18:
±$3.80
(34.73%) —
implied range
$7.14 –
$14.74
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $775.88M | $7.54 | — |
| OABI | OmniAb, Inc. | $670.25M | $4.61 | — |
| TKNO | Alpha Teknova, Inc. | $500.91M | $9.33 | — |
| NRC | NRC HEALTH | $432.88M | $19.57 | — |
| MYGN | MYRIAD GENETICS INC | $398.86M | $4.17 | — |
News headlines (Yahoo Finance, 1h cache)
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
2026-09-25 15:36 · Yahoo
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
2026-09-24 13:12 · Yahoo
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players
2026-09-16 09:05 · Yahoo
Faster Answers, Better Decisions: ADLM 2026 Highlights
2026-08-27 13:12 · Yahoo
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
2026-08-17 09:42 · Yahoo
The 5 Most Interesting Analyst Questions From QuidelOrtho’s Q2 Earnings Call
2026-08-15 14:05 · Yahoo
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript
2026-08-14 00:16 · Yahoo
QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations
2026-08-13 03:18 · Yahoo
Why QuidelOrtho (QDEL) Stock Is Nosediving
2026-08-10 22:05 · Yahoo
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
2026-08-26 08:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.